Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial
- 1 November 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 364 (9448), 1865-1871
- https://doi.org/10.1016/s0140-6736(04)17442-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prophylaxis of opportunistic infections in HIV-infected adults in sub-Saharan Africa: opportunities and obstaclesAIDS, 2002
- Plasmodium falciparum crossresistance between trimethoprim and pyrimethamineThe Lancet, 2001
- Increased Disease Burden and Antibiotic Resistance of Bacteria Causing Severe Community-Acquired Lower Respiratory Tract Infections in Human Immunodeficiency Virus Type 1-Infected ChildrenClinical Infectious Diseases, 2000
- Increased Carriage of Trimethoprim/Sulfamethoxazole‐ResistantStreptococcus pneumoniaein Malawian Children after Treatment for Malaria with Sulfadoxine/PyrimethamineThe Journal of Infectious Diseases, 2000
- Clinical presentation and outcome of Pneumocystis carinii pneumonia in Malawian childrenThe Lancet, 2000
- Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Côte d'Ivoire: a randomised controlled trialThe Lancet, 1999
- Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence studyBMJ, 1996
- Intravenous Immune Globulin for the Prevention of Bacterial Infections in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991